While waiting for UnitedHealth Group’s (NYSE: UNH) purchase of it to finalize, Amedisys Inc. (Nasdaq: AMED) continues to grow its home health segment – primarily through non-Medicare revenue – and its higher-acuity care segment. The company reported its first-quarter earnings late Wednesday, which showed a 10% increase in total same store admissions in home health […]
UnitedHealth Group
It was a turbulent start to the year for the health care giant UnitedHealth Group, driven by the cyberattack on Change Healthcare and a U.S. Department of Justice (DOJ) antitrust investigation. Amid the DOJ investigation, UnitedHealth Group’s planned acquisition of the home health company Amedisys Inc. (Nasdaq: AMED) came into focus, with reports circulating that […]
UnitedHealth Group (NYSE: UNH) and Amedisys Inc. (Nasdaq: AMED) announced combination plans last June, under which home health giant Amedisys would become part of Optum. Amedisys had previously entered into an agreement to merge with infusion therapy company Option Care Health (Nasdaq: OPCH), but UnitedHealth Group’s offer, scale and complementary clinical capabilities were effectively too […]
Thanks to impactful, large-scale transactions over the last decade, the collective face of home-based care has changed forever. Traditional providers in both home health care and personal home care have merged. Payers became involved in the home-based care space like never before. Of late, retailers have too. But it’s often easy to forget how the […]
UnitedHealth Group’s (NYSE:UNH) planned acquisition of Amedisys Inc. (Nasdaq:AMED) is catching further scrutiny. Late Wednesday, a report suggesting that the Department of Justice is considering a lawsuit to block Optum’s takeover of Amedisys surfaced. The deal was first agreed to in June of last year. The news comes just a few weeks after the DOJ […]
In 2023, Medicare Advantage (MA) plan members represented more than half of all Medicare beneficiaries for the first time. In 2024, while penetration continues, there are other trends within MA that home-based care providers should be paying attention to. Seniors have more options than ever when choosing MA plans. But a few of the top […]
Since the news surfaced Tuesday that the Department of Justice had opened an antitrust investigation into UnitedHealth Group (NYSE: UNH), additional questions have bubbled up. Namely, those questions surround the home health provider Amedisys Inc. (Nasdaq: AMED), which agreed to be acquired by UnitedHealth Group’s Optum in June of last year. Will that deal be […]
The Department of Justice is targeting UnitedHealth Group (NYSE: UNH) in an antitrust investigation, The Wall Street Journal reported Tuesday. Specifically, the Justice Department is interviewing subjects around interactions between UnitedHealth Group and its health care provider services arm, Optum. UnitedHealthcare is one of the largest insurers in the country. Meanwhile, Optum is one of […]
Over the next 12-18 months, the mergers and acquisitions that do or do not take place in home-based care will tell a story worth listening to about the future of the space. The context has become monotonous to tell at this point: high interest rates are affecting dealmaking across the country; Medicare Advantage (MA) penetration […]
In addition to high interest rates, there’s another factor slowing down health care and post-acute care M&A, according to a new report. Released last week, Pitchbook’s Q4 health care services report shines a light on the Biden administration’s antitrust and private equity stances, and how those may be affecting dealmaking. For instance, the Humana Inc. […]
Subscribe
Receive industry updates and breaking news from HHCN